HealthEquity, Inc.
HQY Healthcare Health Information Services
HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025.
- Revenue
- +7.64%
- EPS
- +14.5%
- Free cash flow
- −3.44%
- Total debt
- −7.53%
Quarter to July 2026, against a year earlier
Follow HQY
Alert me
HealthEquity, Inc. (HQY) Shares outstanding
HealthEquity, Inc.'s shares outstanding at the end of fiscal 2026 was $87.5M, unchanged from fiscal 2025. At the end of the quarter to 31 July 2026 it was $84.0M. Over the past ten years it has ranged from $51.9M (fiscal 2015) to $88.8M (fiscal 2025); the current reading is higher than 92% of that period. HealthEquity, Inc. ranks 16th of 43 Health Information Services companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2026 | $87.5M | (1.53%) |
| FY2025 | $88.8M | 2.15% |
| FY2024 | $87.0M | 2.98% |
| FY2023 | $84.4M | 1.57% |
| FY2022 | $83.1M | 9.85% |
| FY2021 | $75.7M | 10.56% |
| FY2020 | $68.5M | 8.02% |
| FY2019 | $63.4M | 2.45% |
| FY2018 | $61.9M | 3.27% |
| FY2017 | $59.9M | 1.75% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jul 2026 | $84.0M | (1.17%) |
| Apr 2026 | $85.0M | (2.82%) |
| Jan 2026 | $87.5M | 0.58% |
| Oct 2025 | $87.0M | (0.88%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $220.2M |
| WAY Waystar Holding Corp. compare | $195.9M |
| DOCS Doximity, Inc. compare | $187.8M |
| TEM Tempus AI, Inc. compare | $181.3M |
| PRVA Privia Health Group, Inc. compare | $132.7M |
| HTFL Heartflow, Inc. compare | $86.4M |
| HQY HealthEquity, Inc. | $84.0M |
| HNGE Hinge Health Inc. compare | $83.4M |
| SDGR Schrodinger, Inc. compare | $74.9M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on HQY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement